Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Differential responses to genotoxic agents between induced pluripotent stem cells and tumor cell lines.

Authors: Lu, Yinghua; Xu, Dazhong; Zhou, Jing; Ma, Yupo; Jiang, Yongping; Zeng, Wenxian; Dai, Wei

Published In J Hematol Oncol, (2013 Sep 20)

Abstract: Given potential values of induced pluripotent stem (iPS) cells in basic biomedical research and regenerative medicine, it is important to understand how these cells regulate their genome stability in response to environmental toxins and carcinogens. The present study characterized the effect of Cr(VI), a well-known genotoxic agent and environmental carcinogen, on major molecular components of DNA damage response pathways in human iPS cells. We compared the effect of Cr(VI) on human iPS cells with two established cell lines, Tera-1 (teratoma origin) and BEAS-2B (lung epithelial origin). We also studied the effect of hydrogen peroxide and doxorubicin on modulating DNA damage responses in these cell types. We demonstrated that ATM and p53 phosphorylation is differentially regulated in human iPS cells compared with Tera-1 and BEAS-2B cells after exposure to various genotoxic agents. Moreover, we observed that inhibition of CK2, but not p38, promotes phosphorylation of p53S392 in iPS cells. Combined, our data reveal some unique features of DNA damage responses in human iPS cells.

PubMed ID: 24283650 Exiting the NIEHS site

MeSH Terms: Cell Line, Tumor; Chromium Compounds/toxicity; DNA Damage*; Dose-Response Relationship, Drug; Doxorubicin/toxicity; Humans; Hydrogen Peroxide/toxicity; Induced Pluripotent Stem Cells/cytology; Induced Pluripotent Stem Cells/drug effects*; Induced Pluripotent Stem Cells/metabolism; Lung Neoplasms/genetics; Lung Neoplasms/metabolism; Mutagens/toxicity*; Phosphorylation; Teratoma/genetics; Teratoma/metabolism; Tumor Suppressor Protein p53/metabolism

Back
to Top